{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:46:59Z","timestamp":1790221619770,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"MED-EL Corporation","award":["15138"],"award-info":[{"award-number":["15138"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ejpb.2020.03.005","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T22:39:29Z","timestamp":1584052769000},"page":"143-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"special_numbering":"C","title":["Intratympanic application of poloxamer 407 hydrogels results in sustained N-acetylcysteine delivery to the inner ear"],"prefix":"10.1016","volume":"150","author":[{"given":"Julia Clara","family":"Gausterer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nodir","family":"Saidov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navid","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengjing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gottfried","family":"Reznicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Arnoldner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Gabor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clemens","family":"Honeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2020.03.005_b0005","unstructured":"World Health Organization Geneva 21th WHO Essential Medicines List (EML), https:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/en\/, June 2019 (accessed January 06, 2020)."},{"key":"10.1016\/j.ejpb.2020.03.005_b0010","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198812153192401","article-title":"Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)","volume":"319","author":"Smilkstein","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejpb.2020.03.005_b0015","unstructured":"National Cancer Institute, NCI Thesaurus, Acetylcysteine (Code C200), https:\/\/ncit.nci.nih.gov\/ncitbrowser\/ConceptReport.jsp?dictionary=NCI_Thesaurus&ns=NCI_Thesaurus&code=C200, Version 19.12e (Release Date: 2019-12-30) (accessed January 19, 2020)."},{"key":"10.1016\/j.ejpb.2020.03.005_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2019.00300","article-title":"Local drug delivery for prevention of hearing loss","volume":"13","author":"Rybak","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejpb.2020.03.005_b0025","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1200\/JCO.1989.7.6.754","article-title":"Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation","volume":"7","author":"Schell","year":"1989","journal-title":"J. Clin. Oncol. Offic. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0030","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/bjc.1998.226","article-title":"Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer","volume":"77","author":"Bokemeyer","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ejpb.2020.03.005_b0035","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1200\/JCO.2016.66.8822","article-title":"Comprehensive Audiometric analysis of hearing impairment and tinnitus after cisplatin-based chemotherapy in survivors of adult-onset cancer","volume":"34","author":"Frisina","year":"2016","journal-title":"J. Clin. Oncol. Offic.J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0040","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1200\/JCO.2016.69.2319","article-title":"Group-wide, prospective study of ototoxicity assessment in children receiving cisplatin chemotherapy (ACCL05C1): a report from the children's oncology group","volume":"35","author":"Knight","year":"2017","journal-title":"J. Clin. Oncol. Offic. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0045","doi-asserted-by":"crossref","unstructured":"E. Clemens, A.C. de Vries, A. Am Zehnhoff-Dinnesen, W.J. Tissing, J.J. Loonen, S.F. Pluijm, E. van Dulmen-den Broeder, D. Bresters, B. Versluys, L.C. Kremer, H.J. van der Pal, S.J. Neggers, M. van Grotel, M.v.d.H.-E. M, Hearing loss after platinum treatment is irreversible in noncranial irradiated childhood cancer survivors, Pediatric hematology and oncology, 34 (2017) 120-129. https:\/\/doi.org\/10.1080\/08880018.2017.1323985.","DOI":"10.1080\/08880018.2017.1323985"},{"key":"10.1016\/j.ejpb.2020.03.005_b0050","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/01.mph.0000141348.62532.73","article-title":"Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss","volume":"26","author":"Bertolini","year":"2004","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0055","doi-asserted-by":"crossref","first-page":"e1229","DOI":"10.1542\/peds.2007-0178","article-title":"Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group","volume":"120","author":"Gurney","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.ejpb.2020.03.005_b0060","first-page":"4053","article-title":"Treatment-induced hearing loss and adult social outcomes in survivors of childhood CNS and non-CNS solid tumors: Results from the St","volume":"121","author":"Brinkman","year":"2015","journal-title":"Jude Lifetime Cohort Study, Cancer"},{"key":"10.1016\/j.ejpb.2020.03.005_b0065","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1097\/00005537-200107000-00005","article-title":"L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity","volume":"111","author":"Feghali","year":"2001","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ejpb.2020.03.005_b0070","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1097\/00129492-200411000-00009","article-title":"Prevention of cisplatin ototoxicity using transtympanic N-acetylcysteine and lactate","volume":"25","author":"Choe","year":"2004","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.ejpb.2020.03.005_b0075","unstructured":"D.T. Dickey, L. Muldoon, D.F. Kraemer, E.A. Neuwelt, Protection against cisplatin ototoxicity by N-acetylcysteine in a rat model, 2004."},{"key":"10.1016\/j.ejpb.2020.03.005_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/COC.0b013e31822e006d","article-title":"Transtympanic injections of N-acetylcysteine for the prevention of cisplatin-induced ototoxicity: a feasible method with promising efficacy","volume":"36","author":"Riga","year":"2013","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0085","doi-asserted-by":"crossref","first-page":"E87","DOI":"10.1002\/lary.24360","article-title":"Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients","volume":"124","author":"Yoo","year":"2014","journal-title":"Laryngoscope"},{"issue":"8","key":"10.1016\/j.ejpb.2020.03.005_b0090","doi-asserted-by":"crossref","first-page":"BR179","DOI":"10.12659\/MSM.881894","article-title":"Dose-dependent protection on cisplatin-induced ototoxicity \u2013 an electrophysiological study on the effect of three antioxidants in the Sprague-Dawley rat animal model","volume":"17","author":"Lorito","year":"2011","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ejpb.2020.03.005_b0095","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0161-813X(00)00010-3","article-title":"Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy","volume":"22","author":"Li","year":"2001","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.ejpb.2020.03.005_b0100","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1067\/mhn.2002.125299","article-title":"Round window application of D-methionine provides complete cisplatin otoprotection","volume":"126","author":"Korver","year":"2002","journal-title":"Otolaryngol.\u2013Head Neck Surg. : Offic. J. Am. Acad. Otolaryngol.-Head Neck Surgery"},{"key":"10.1016\/j.ejpb.2020.03.005_b0105","first-page":"309","article-title":"Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity","volume":"6","author":"Muldoon","year":"2000","journal-title":"Clin. Cancer Res. Offic. J. Am. Associat. Cancer Res."},{"key":"10.1016\/j.ejpb.2020.03.005_b0110","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0028-3908(03)00194-1","article-title":"Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig","volume":"45","author":"Wang","year":"2003","journal-title":"Neuropharmacology"},{"issue":"25","key":"10.1016\/j.ejpb.2020.03.005_b0115","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","article-title":"Sodium thiosulfate for protection from cisplatin-induced hearing loss","volume":"378","author":"Brock","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejpb.2020.03.005_b0120","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s11060-014-1657-1","article-title":"N-acetylcysteine chemoprotection without decreased cisplatin antitumor efficacy in pediatric tumor models","volume":"121","author":"Muldoon","year":"2015","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0125","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00280-007-0597-2","article-title":"Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models","volume":"62","author":"Dickey","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.heares.2004.02.007","article-title":"Protection against cisplatin-induced ototoxicity by N-acetylcysteine in a rat model","volume":"193","author":"Thomas Dickey","year":"2004","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2020.03.005_b0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0378-5955(02)00277-0","article-title":"D-Methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics","volume":"165","author":"Ekborn","year":"2002","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2020.03.005_b0140","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MAO.0b013e3182009d29","article-title":"OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders","volume":"32","author":"Piu","year":"2011","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0145","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000322504","article-title":"Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation","volume":"16","author":"Salt","year":"2011","journal-title":"Audiol. Neurootol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1159\/000241896","article-title":"Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach","volume":"14","author":"Wang","year":"2009","journal-title":"Audiol. Neurootol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0155","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000358165","article-title":"Sustained release of triamcinolone acetonide from an intratympanically applied hydrogel designed for the delivery of high glucocorticoid doses","volume":"19","author":"Honeder","year":"2014","journal-title":"Audiol. Neurootol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0160","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000487662","article-title":"Evaluation of sustained-release steroid hydrogels in a guinea pig model for noise-induced hearing loss","volume":"23","author":"Zhu","year":"2018","journal-title":"Audiol. Neurootol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0165","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijpharm.2014.05.057","article-title":"Preclinical evaluation of thermoreversible triamcinolone acetonide hydrogels for drug delivery to the inner ear","volume":"471","author":"Engleder","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.03.005_b0170","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.heares.2018.03.002","article-title":"Pharmacokinetic principles in the inner ear: Influence of drug properties on intratympanic applications","volume":"368","author":"Salt","year":"2018","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2020.03.005_b0175","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jneumeth.2005.10.008","article-title":"Perilymph sampling from the cochlear apex: a reliable method to obtain higher purity perilymph samples from scala tympani","volume":"153","author":"Salt","year":"2006","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejpb.2020.03.005_b0180","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.otohns.2010.02.007","article-title":"Transtympanic Ringer's lactate application in the prevention of cisplatinum-induced ototoxicity in a chinchilla animal model","volume":"143","author":"Munguia","year":"2010","journal-title":"Otolaryngol.\u2013Head Neck Surg. Offic. J. Am. Acad. Otolaryngol.-Head Neck Surg."},{"key":"10.1016\/j.ejpb.2020.03.005_b0185","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1002\/jps.21157","article-title":"Physicochemical characterisation of a novel thermogelling formulation for percutaneous penetration of 5-aminolevulinic acid","volume":"97","author":"Gruning","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2020.03.005_b0190","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijpharm.2012.07.048","article-title":"Rheological characterization and permeation behavior of poloxamer 407-based systems containing 5-aminolevulinic acid for potential application in photodynamic therapy","volume":"437","author":"van Hemelrijck","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2020.03.005_b0195","series-title":"Das Rheologie Handbuch : F\u00fcr Anwender von Rotations- und Oszillations-Rheometern, 3. \u00fcberarbeitete Auflage","author":"Mezger","year":"2010"},{"key":"10.1016\/j.ejpb.2020.03.005_b0200","unstructured":"Anton Paar, Amplitude sweeps, https:\/\/wiki.anton-paar.com\/corp-de\/amplituden-sweeps\/, 2020 (accessed January 5, 2020)."},{"key":"10.1016\/j.ejpb.2020.03.005_b0205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.heares.2016.08.001","article-title":"Effects of sustained release dexamethasone hydrogels in hearing preservation cochlear implantation","volume":"341","author":"Honeder","year":"2016","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2020.03.005_b0210","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/00005537-199910000-00021","article-title":"Cochlear fluid space dimensions for six species derived from reconstructions of three-dimensional magnetic resonance images","volume":"109","author":"Thorne","year":"1999","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ejpb.2020.03.005_b0215","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0021-9673(98)00538-X","article-title":"Determination of l-lysine N-acetylcysteinate and its mono- and dimeric related compounds by liquid chromatography\u2013mass spectrometry","volume":"819","author":"Toussaint","year":"1998","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.ejpb.2020.03.005_b0220","unstructured":"SwissADME, http:\/\/www.swissadme.ch\/, 2018 (accessed January 26, 2019)."},{"key":"10.1016\/j.ejpb.2020.03.005_b0225","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/978-1-4612-0757-3_3","article-title":"Homeostatic mechanisms in the cochlea","author":"Wangemann","year":"1996","journal-title":"Cochlea"},{"key":"10.1016\/j.ejpb.2020.03.005_b0230","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/MAO.0b013e31818658ea","article-title":"Permeability of the round window membrane is influenced by the composition of applied drug solutions and by common surgical procedures","volume":"29","author":"Mikulec","year":"2008","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1288\/00005537-198806001-00002","article-title":"Experimental studies on round window structure: function and permeability","volume":"98","author":"Goycoolea","year":"1988","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ejpb.2020.03.005_b0240","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s10162-002-2036-8","article-title":"Distribution of gentamicin in the guinea pig inner ear after local or systemic application","volume":"4","author":"Imamura","year":"2003","journal-title":"J. Assoc. Res. Otolaryngol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0245","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1002\/lary.20892","article-title":"The role of intratympanic lactate injection in the prevention of cisplatin-induced ototoxicity","volume":"120","author":"Nader","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.ejpb.2020.03.005_b0250","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0378-5955(03)00330-7","article-title":"Round window pH manipulation alters the ototoxicity of systemic cisplatin","volume":"187","author":"Tanaka","year":"2004","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2020.03.005_b0255","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000072253","article-title":"Comparison of the protective efficacy of neurotrophins and antioxidants for vibration-induced trauma","volume":"65","author":"Zou","year":"2003","journal-title":"ORL J. Otorhinolaryngol. Relat. Spec."},{"key":"10.1016\/j.ejpb.2020.03.005_b0260","unstructured":"Prescribing information ACETADOTE (acetylcysteine) injection, for intravenous use https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2017\/021539s016lbl.pdf, 2017 (accessed April 4, 2019)."},{"key":"10.1016\/j.ejpb.2020.03.005_b0265","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0378-5955(01)00223-4","article-title":"Quantification of solute entry into cochlear perilymph through the round window membrane","volume":"154","author":"Salt","year":"2001","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2020.03.005_b0270","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1080\/000164801300366552","article-title":"Clinical aspects of round window membrane permeability under normal and pathological conditions","volume":"121","author":"Goycoolea","year":"2001","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0275","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00464276","article-title":"Permeability of the labyrinthine windows in guinea pigs","volume":"233","author":"Tanaka","year":"1981","journal-title":"Archives Oto-rhino-laryngol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0280","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00016488809107371","article-title":"Anatomy of the round window. A histopathological study with a graphic reconstruction method","volume":"106","author":"Okuno","year":"1988","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0285","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0378-5955(01)00375-6","article-title":"Quantitative anatomy of the round window and cochlear aqueduct in guinea pigs","volume":"162","author":"Ghiz","year":"2001","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2020.03.005_b0290","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/(SICI)1097-0029(19970201)36:3<201::AID-JEMT8>3.0.CO;2-R","article-title":"Round window membrane. Structure function and permeability: a review","volume":"36","author":"Goycoolea","year":"1997","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.ejpb.2020.03.005_b0295","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF00465550","article-title":"Freeze-fracture aspects of the junctional complexes in the round window membrane","volume":"217","author":"Franke","year":"1977","journal-title":"Arch Otorhinolaryngol"},{"key":"10.1016\/j.ejpb.2020.03.005_b0300","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.heares.2011.11.012","article-title":"Marker entry into vestibular perilymph via the stapes following applications to the round window niche of guinea pigs","volume":"283","author":"Salt","year":"2012","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2020.03.005_b0305","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000241892","article-title":"Principles of local drug delivery to the inner ear","volume":"14","author":"Salt","year":"2009","journal-title":"Audiol. Neurotol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0310","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0196-0709(82)80016-1","article-title":"Transport characteristics of the blood\u2014Perilymph barrier","volume":"3","author":"Juhn","year":"1982","journal-title":"Am. J. Otolaryngol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0315","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000073516","article-title":"Cortisol levels in the human perilymph after intravenous administration of prednisolone","volume":"8","author":"Niedermeyer","year":"2003","journal-title":"Audiol. Neurootol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0320","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1097\/MAO.0b013e31815aee21","article-title":"Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph","volume":"28","author":"Bird","year":"2007","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0325","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0378-5955(02)00613-5","article-title":"Local administration of antioxidants to the inner ear. Kinetics and distribution(1)","volume":"173","author":"Laurell","year":"2002","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2020.03.005_b0330","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5955(01)00224-6","article-title":"Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals","volume":"155","author":"Sha","year":"2001","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2020.03.005_b0335","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0378-5955(99)00017-9","article-title":"Effect of 4-methylthiobenzoic acid on cisplatin-induced ototoxicity in the rat","volume":"131","author":"Kamimura","year":"1999","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2020.03.005_b0340","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.heares.2005.12.001","article-title":"Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration","volume":"212","author":"Hahn","year":"2006","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2020.03.005_b0345","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00280-011-1656-2","article-title":"Prevention of cisplatin-induced hearing loss by administration of a thiosulfate-containing gel to the middle ear in a guinea pig model","volume":"68","author":"Berglin","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0350","doi-asserted-by":"crossref","unstructured":"A.A. Mikulec, S.K. Plontke, J.J. Hartsock, A.N. Salt, Entry of substances into perilymph through the bone of the otic capsule after intratympanic applications in guinea pigs: implications for local drug delivery in humans, Otology & neurotology : official publication of the American Otological Society, Am. Neurotol. Soc. Europ. Academy Otol. Neurotol., 30 (2009) 131-138. https:\/\/doi.org\/10.1097\/MAO.0b013e318191bff8.","DOI":"10.1097\/MAO.0b013e318191bff8"},{"key":"10.1016\/j.ejpb.2020.03.005_b0355","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/00016480310001042","article-title":"High variability of perilymphatic entry of neutral molecules through the round window","volume":"123","author":"Chelikh","year":"2003","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0360","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0378-5955(03)00137-0","article-title":"Contamination of perilymph sampled from the basal cochlear turn with cerebrospinal fluid","volume":"182","author":"Salt","year":"2003","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2020.03.005_b0365","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1006\/abio.2000.4980","article-title":"Determination of reduced, protein-unbound, and total concentrations of N-acetyl-L-cysteine and L-cysteine in rat plasma by postcolumn ligand substitution high-performance liquid chromatography","volume":"290","author":"Harada","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejpb.2020.03.005_b0370","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3109\/00016487509124654","article-title":"Protein concentration in the guinea-pig perilymph","volume":"79","author":"Scheibe","year":"1975","journal-title":"Acta Otolaryngol."},{"key":"10.1016\/j.ejpb.2020.03.005_b0375","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0378-5955(92)90071-T","article-title":"Protein profiles of perilymph and endolymph of the guinea pig","volume":"63","author":"Thalmann","year":"1992","journal-title":"Hear. Res."},{"key":"10.1016\/j.ejpb.2020.03.005_b0380","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s10544-016-0046-2","article-title":"A dual wedge microneedle for sampling of perilymph solution via round window membrane","volume":"18","author":"Watanabe","year":"2016","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.ejpb.2020.03.005_b0385","first-page":"383","volume":"31","author":"Hein","year":"2003","journal-title":"Labordiagnostische Referenzbereiche bei Meerschweinchen"},{"key":"10.1016\/j.ejpb.2020.03.005_b0390","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jconrel.2008.04.013","article-title":"Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers","volume":"130","author":"Batrakova","year":"2008","journal-title":"J. Controll. Release : Offic. J. Controll. Release Soc."},{"issue":"1-2","key":"10.1016\/j.ejpb.2020.03.005_b0395","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0927-7757(94)03028-X","article-title":"Poly(ethylene oxide)\u22c5poly(propylene oxide)\u22c5poly(ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling","volume":"96","author":"Alexandridis","year":"1995","journal-title":"Colloids Surf., A"},{"key":"10.1016\/j.ejpb.2020.03.005_b0400","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10030159","article-title":"Mucosal applications of poloxamer 407-based hydrogels: an overview","volume":"10","author":"Giuliano","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2020.03.005_b0405","unstructured":"J.J. Escobar-Chavez, M. Lopez-Cervantes, A. Naik, Y.N. Kalia, D. Quintanar-Guerrero, A. Ganem-Quintanar, Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 9 (2006) 339-358."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120300618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120300618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:37:07Z","timestamp":1760546227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641120300618"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":81,"alternative-id":["S0939641120300618"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.03.005","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intratympanic application of poloxamer 407 hydrogels results in sustained N-acetylcysteine delivery to the inner ear","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}